PARPARADIGM BIOPHARMACEUTICALS LIMITED..
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 13 Aug 2026, 19:33 | 80% Safety Review Complete, September IA on Track | Company Update | — | 11001 | |
| 31 July 2026, 02:56 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 30 July 2026, 19:55 | June 2026 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 27 July 2026, 18:17 | Notification of cessation of securities - PAR | Other | — | 06027 | |
| 22 July 2026, 18:18 | Paradigm Receives $5.75m R&D Tax Incentive Refund | Company Update | MS | 11001 | |
| 18 July 2026, 04:51 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 13 July 2026, 23:32 | Notice under Section 708A | Securities Administration | — | 06018 | |
| 13 July 2026, 23:21 | Notification regarding unquoted securities - PAR | Other | — | 06021 | |
| 13 July 2026, 23:14 | Drawdown of Tranche 4 under the Convertible Note Facility | Securities Administration | MS | 06009 | |
| 2 July 2026, 03:52 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 30 June 2026, 03:01 | Notification of cessation of securities - PAR | Other | — | 06027 | |
| 30 June 2026, 02:55 | Notification of cessation of securities - PAR | Other | — | 06027 | |
| 19 June 2026, 03:46 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 19 June 2026, 03:46 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 19 June 2026, 03:29 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 17 June 2026, 20:52 | Listing of Options - Top 20 Holders and Distribution Reports | Securities Administration | — | 03002 | |
| 17 June 2026, 20:50 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 15 June 2026, 19:11 | PAR Completes Enrolment in Pivotal Phase 3 | Company Update | MS | 11001 | |
| 12 June 2026, 04:29 | Options Prospectus | Securities Administration | — | 06009, 06010 | |
| 11 June 2026, 22:56 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 6 June 2026, 04:34 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 6 June 2026, 04:34 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 June 2026, 18:20 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 4 June 2026, 03:34 | Notification of cessation of securities - PAR | Other | — | 06027 | |
| 3 June 2026, 03:31 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 2 June 2026, 20:18 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 1 June 2026, 22:30 | Update - Proposed issue of securities - PAR | Securities Administration | — | 06013 | |
| 1 June 2026, 20:34 | Results of Share Purchase Plan | Capital Raising | MS | 06017 | |
| 12 May 2026, 23:16 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 5 May 2026, 18:15 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 1 May 2026, 19:04 | Cleansing Notice | Securities Administration | — | 06018 | |
| 1 May 2026, 19:01 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 1 May 2026, 03:03 | Variation to Convertible Securities Agreement | Capital Raising | — | 03022, 06009, 12008 | |
| 30 Apr 2026, 23:19 | Share Purchase Plan - Offer Booklet | Capital Raising | — | 06017, 16002 | |
| 30 Apr 2026, 18:13 | DSMB 20% Review Supports Phase 3, Moldova Activated | Company Update | MS | 11001 | |
| 29 Apr 2026, 18:26 | OARSI Theatre Presentation Showcases iPPS Biomarker Data | Company Administration | — | 12008 | |
| 27 Apr 2026, 20:07 | March 2026 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 20:06 | Proposed issue of securities - PAR | Securities Administration | — | 06013 | |
| 27 Apr 2026, 20:06 | Proposed issue of securities - PAR | Securities Administration | — | 06013 | |
| 27 Apr 2026, 20:05 | Upsized $14M Placement Extends Runway Post IA | Capital Raising | MS | 03026, 06003, 06017, 09014 | |
| 23 Apr 2026, 18:48 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 9 Apr 2026, 02:36 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 2 Apr 2026, 20:58 | Paradigm Announces OA Research Collaboration in UK | Company Update | — | 11001 | |
| 31 Mar 2026, 19:22 | Paradigm Achieves 50% Patient Dosing in Phase 3 | Company Update | MS | 11001 | |
| 20 Mar 2026, 20:27 | Hong Kong Site Activated for Phase 3 OA Study | Company Update | — | 11001 | |
| 17 Mar 2026, 04:17 | Application for quotation of securities - PAR | Other | — | 06020 | |
| 27 Feb 2026, 19:11 | Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 24 Feb 2026, 03:34 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 24 Feb 2026, 03:32 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 20 Feb 2026, 02:37 | Notification regarding unquoted securities - PAR | Other | — | 06021 |
1–50 of 92
1 / 2